[1]
“Rituximab to Abbreviate Plasma Exchange in Anti-CFH (Complement Factor H) Antibody Mediated Atypical HUS”, IJKD, vol. 13, no. 2, pp. 134–138, Apr. 2019, Accessed: May 19, 2024. [Online]. Available: https://www.ijkd.org/index.php/ijkd/article/view/4138